Saniona Ab Stock Fundamentals
| SANION Stock | SEK 1.89 0.06 3.28% |
Saniona AB fundamentals help investors to digest information that contributes to Saniona AB's financial success or failures. It also enables traders to predict the movement of Saniona Stock. The fundamental analysis module provides a way to measure Saniona AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Saniona AB stock.
Saniona |
Saniona AB Company Return On Equity Analysis
Saniona AB's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Saniona AB Return On Equity | -1.38 |
Most of Saniona AB's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Saniona AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Saniona AB has a Return On Equity of -1.3844. This is 94.22% lower than that of the Biotechnology sector and 96.2% lower than that of the Health Care industry. The return on equity for all Sweden stocks is notably higher than that of the company.
Saniona AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Saniona AB's current stock value. Our valuation model uses many indicators to compare Saniona AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Saniona AB competition to find correlations between indicators driving Saniona AB's intrinsic value. More Info.Saniona AB is rated second in return on equity category among related companies. It is rated second in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Saniona AB by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Saniona AB's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Saniona AB's earnings, one of the primary drivers of an investment's value.Saniona Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Saniona AB's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Saniona AB could also be used in its relative valuation, which is a method of valuing Saniona AB by comparing valuation metrics of similar companies.Saniona AB is currently under evaluation in return on equity category among related companies.
Saniona Fundamentals
| Return On Equity | -1.38 | |||
| Return On Asset | -0.5 | |||
| Operating Margin | (19.74) % | |||
| Current Valuation | 155.94 M | |||
| Shares Outstanding | 62.39 M | |||
| Shares Owned By Insiders | 22.91 % | |||
| Shares Owned By Institutions | 20.60 % | |||
| Price To Earning | (176.87) X | |||
| Price To Book | 2.10 X | |||
| Price To Sales | 12.55 X | |||
| Revenue | 10.48 M | |||
| Gross Profit | 5.85 M | |||
| EBITDA | (398.86 M) | |||
| Net Income | (410.9 M) | |||
| Cash And Equivalents | 356.86 M | |||
| Cash Per Share | 1.96 X | |||
| Total Debt | 92.97 M | |||
| Debt To Equity | 34.70 % | |||
| Current Ratio | 1.29 X | |||
| Book Value Per Share | 1.46 X | |||
| Cash Flow From Operations | (345.04 M) | |||
| Earnings Per Share | (7.39) X | |||
| Target Price | 6.5 | |||
| Number Of Employees | 25 | |||
| Beta | 0.74 | |||
| Market Capitalization | 196.21 M | |||
| Total Asset | 440.25 M | |||
| Retained Earnings | (34 M) | |||
| Working Capital | 49 M | |||
| Current Asset | 58 M | |||
| Current Liabilities | 9 M | |||
| Z Score | 1.2 | |||
| Net Asset | 440.25 M |
About Saniona AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Saniona AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Saniona AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Saniona AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Saniona AB , a research and development company, engages in the development of drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases, and treatment of pain in Denmark. Saniona AB was founded in 2011 and is headquartered in Ballerup, Denmark. Saniona AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 21 people.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Saniona AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Saniona Stock analysis
When running Saniona AB's price analysis, check to measure Saniona AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Saniona AB is operating at the current time. Most of Saniona AB's value examination focuses on studying past and present price action to predict the probability of Saniona AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Saniona AB's price. Additionally, you may evaluate how the addition of Saniona AB to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |